Funder: German Federal Ministry for Research, Technology and Space (Bundesministerium für Forschung, Technologie und Raumfahrt, BMFTR)
Period: 2026-2029.
Project leader: Dr. Stefan Hadžić, Excellence Cluster Cardio-Pulmonary Institute (CPI), Justus Liebig University (JLU), Giessen, Germany
Project leader in Serbia: Dr. Dragica Mićanović, Department of Immunology, IBISS
Team members from IBISS:
Maša Marković, Department of Immunology, IBISS
The aim of this project is to redefine the pathological paradigm of chronic obstructive pulmonary disease (COPD) by reframing protein nitration not merely as a passive biomarker of oxidative stress, but as an active, therapeutically targetable driver of autoimmune-mediated disease progression. Although current medications can alleviate symptoms, COPD remains incurable. Our research aims to demonstrate that peroxynitrite stress generates highly immunogenic 3-nitrotyrosine (3-NT) neoepitopes relevant to COPD. The hypothesis is that these neoepitopes overcome immune tolerance and trigger a self-sustaining autoimmune cascade that persists even after the environmental stressors are eliminated. By elucidating these connections, the project aims to develop and validate first-in-class, patentable neutralizing antibodies designed to successfully halt disease progression and enable endogenous lung repair. Structurally, the project enhances the research infrastructure in the Western Balkans by enabling the Siniša Stanković Institute for Biological Research (IBISS) to directly procure and establish advanced methods such as the FlexiVent system for measuring lung function. Where possible, the project results and insights gained will be translated into commercial therapies, taking intellectual property (IP) into account. The project aims to enable the production of standardized diagnostic kits and the generation of patentable neutralizing antibodies through strategic partnerships with industry, which can then be approved for market launch following future clinical trials.
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.